MACROCYCLIC INHIBITORS OF THE PD-1/PD-L1 AND CD80(B7-1)/PD-L1 PROTEIN/PROTEIN INTERACTIONS
申请人:Bristol-Myers Squibb Company
公开号:EP3626732A1
公开(公告)日:2020-03-25
The present disclosure provides novel macrocyclic peptides which inhibit the PD-1/PD-L1 and PD-L1/CD80 protein/protein interaction, and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
本公开提供了新型大环肽,它们能抑制 PD-1/PD-L1 和 PD-L1/CD80 蛋白/蛋白相互作用,因此可用于改善各种疾病,包括癌症和传染性疾病。